GlassScriptPhysician profile
Matthew J Ross
NPI 1316034010
$1,656.60
in general payments reported to CMS, 2019-2025
14 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.32 · 2020: $62.67 · 2021: $560 · 2022: $262 · 2023: $125 · 2024: $348 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $380.15 | 2022-2024 | |
| Kuros Biosciences USA, INC | $360.60 | 2021-2025 | Magnetos |
| Abbott Laboratories | $163.50 | 2021 | |
| Boston Scientific Corporation | $154.08 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $150.00 | 2024 | Senza |
| Depuy Synthes Sales INC. | $114.83 | 2020-2024 | Spine & Trauma 3d Navigation, Fibergraft Bg Morsels |
| Si-Bone, INC. | $88.63 | 2019-2024 | |
| Providence Medical Technology, INC. | $62.47 | 2023 | |
| Stryker Corporation | $60.21 | 2019-2023 | Core |
| Intrinsic Therapeutics | $40.27 | 2025 | Barricaid Acd (Annular Closure Device) |
| Orthofix Medical, INC. | $30.87 | 2025 | Spinal-Stim |
| Relievant Medsystems, INC. | $24.09 | 2023 | Intracept |
| Surgalign Spine Technologies, INC. | $16.26 | 2021 | |
| Electronic Waveform Lab, INC. | $10.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.